Literature DB >> 2681251

Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2.

B B Kvinesdal1, C M Nielsen, A G Poulsen, N Højlyng.   

Abstract

A total of 215 serum samples were tested for antibodies against human immunodeficiency virus type 2 (HIV-2) with an immunofluorescence assay (IFA). Some samples originated from Denmark and some originated from Guinea-Bissau. The IFA results were compared with enzyme-linked immunosorbent assay (ELISA) and Western (immuno-) blot (WB) results. Twenty-nine serum samples were found to be true positive for HIV-2 antibodies as judged from WB and radioimmunoprecipitation results; all of these were also found to be positive in the HIV-2 IFA. Of 80 serum samples originating from HIV-1-infected persons, 60% showed reactivity in the HIV-2 ELISA, and 51% cross-reacted with at least one band in the HIV-2 WB. None of the sera cross-reacted in the HIV-2 IFA. A total of five serum samples (three African and two Danish) gave unspecific results in the HIV-2 IFA. It is concluded that the HIV-2 IFA is more specific and at least as sensitive as a first-generation ELISA and that IFA is superior to WB in discriminating between HIV-1 and HIV-2 infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681251      PMCID: PMC267066          DOI: 10.1128/jcm.27.11.2502-2504.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola.

Authors:  B Böttiger; I B Palme; J L da Costa; L F Dias; G Biberfeld
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

2.  Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection.

Authors:  R S Tedder; T O'Connor; A Hughes; H N'jie; T Corrah; H Whittle
Journal:  Lancet       Date:  1988-10-22       Impact factor: 79.321

3.  Immunofluorescence tests for HIV antibody and their value as confirmatory tests.

Authors:  G van der Groen; G Vercauteren; P Piot
Journal:  J Virol Methods       Date:  1987-08       Impact factor: 2.014

4.  The global distribution of human immunodeficiency virus type 2 (HIV-2) infection.

Authors:  C R Horsburgh; S D Holmberg
Journal:  Transfusion       Date:  1988 Mar-Apr       Impact factor: 3.157

5.  Discrimination between antibodies to HIV and to related retroviruses using site-directed serology.

Authors:  E Norrby; G Biberfeld; F Chiodi; A von Gegerfeldt; A Nauclér; E Parks; R Lerner
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

6.  Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies.

Authors:  J R Carlson; J Yee; S H Hinrichs; M L Bryant; M B Gardner; N C Pedersen
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

7.  Antibody response to human immunodeficiency virus after primary infection.

Authors:  D A Cooper; A A Imrie; R Penny
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

8.  Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections.

Authors:  J W Gnann; J B McCormick; S Mitchell; J A Nelson; M B Oldstone
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

9.  Antigen-antibody reaction in solution in capture competition immunoassay for human immunodeficiency virus antibodies.

Authors:  C M Nielsen; B Kvinesdal; B F Vestergaard
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

10.  Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells.

Authors:  E G Sandstrom; R T Schooley; D D Ho; R Byington; M G Sarngadharan; M E MacLane; M Essex; R C Gallo; M S Hirsch
Journal:  Transfusion       Date:  1985 Jul-Aug       Impact factor: 3.157

View more
  3 in total

1.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

2.  Construction of recombinant fusion protein of influenza, a virus neuraminidase and heat shock protein 70 gene: expression in baculovirus and bioactivity.

Authors:  M Moghaddam Pour; H Keivani; S H Masoudi; S H Monavari; M Najafi
Journal:  J Med Life       Date:  2015

Review 3.  Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.

Authors:  Sandipan Ray; Sandip K Patel; Vipin Kumar; Jagruti Damahe; Sanjeeva Srivastava
Journal:  Proteomics Clin Appl       Date:  2013-12-27       Impact factor: 3.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.